Pharmacists ‘not currently qualified’ for UTI trial

woman on toilet

A pharmacist and several doctors have again called for the Queensland UTI trial to be halted, citing concerns about antimicrobial resistance

Senior Infectious Diseases Pharmacist, Aryan Shahabi-Sirjani, Chair of the NSW Antimicrobial Stewardship Pharmacist Network (NASPN), said in a statement this week that proposals for a similar trial in the UK had been withdrawn because of concerns about increasing resistance to antibiotics.

He said that a similar trial in New Zealand led to the region having the country’s highest use of trimethoprim and a corresponding increase in rates of resistance to the drug by the common bacteria that cause UTIs.

NASPN made a submission to the TGA last year opposing what it calls the “downscheduling” of trimethoprim to enable pharmacists to prescribe it.

“Pharmacists in Australia are not currently qualified to diagnose UTIs (which requires) utilising the appropriate history, physical examination and investigations of the patient,” the group submitted to the TGA.

“There is an inherent risk of pharmacists missing a differential diagnosis or complications of a UTI. The most important complication that bears significant mortality is sepsis.”

In the submission, Mr Shahabi-Sirjani wrote patient care needed to be delivered in a holistic manner, using all available diagnostic tools and skills, rather than what he calls a “fragmented” fashion enabled by the pharmacy trial.

In the same statement, AMA Queensland President Dr Chris Perry said doctors have grave concerns about the risk of misdiagnosis of symptoms and the threat of patients’ conditions worsening.

“This is a really dangerous initiative and one that doctors have vehemently opposed,” Dr Perry said. “Unfortunately, our concerns have fallen on deaf ears.

“It takes unnecessary and unwanted risks with patients’ health,” he said.

“AMA Queensland calls on the State Government to put an end to the trial and work with doctors and pharmacists on ways to deliver collaborative, efficient and safe patient care.”

Reporting on the statement, RACGP’s newsGP spoke to RACGP Queensland chair Dr Bruce Willett, who said that antimicrobial resistance was one of two top health risks faced by international health stakeholders, the other being pandemics such as COVID-19.

“Antimicrobial resistance is in a sense very similar to this pandemic, both have the potential to kill millions,” he said.
“Antimicrobial resistance is the slow-motion version of COVID-19. We have seen the importance in Australia of being able to plan for the pandemic.
“But, unfortunately, in Queensland there is a tendency to ignore the growing tsunami of antimicrobial resistance and to go the other way, rather than to improve it.”

He said that “retail pharmacies” were not a suitable setting for patients to receive this treatment, and that the commentary by NASPN illustrates a difference between “retail pharmacies and hospital pharmacists”.

Previous MedAdvisor reports ‘record’ revenue
Next Pharmacist self-administered ADHD drugs

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.


  1. Anonymous

    I completely agree with doctor Berry. Retail pharmacists are not equipped to diagnose UTI. Pharmacists are qualified but not enabled or utilised. Greedy pharmacy owners do not deserve this extra quality to milk of their employee pharmacists.


      Agree 100%. Pharmacists are sick of having to play doctor without extra remuneration. A stronger union is needed. This is one of the main reasons pharmacists are leaving the profession. They have simply had enough of all the extra work without proper reward. Employee Pharmacists that accept this are foolish and/or blind. It’s not right.

      Look at Bunnings. They have given their staff a $2000 bonus in appreciation for being ‘essential workers’ during this critical time.
      Pharmacists appreciation is only fake lip service. Again, another reason why good pharmacists are leaving. Not good. Good luck.

  2. Hey all “UTI Pharmacist Prescribing advocates”, how about putting much needed time and effort into proposals that actually unite the health professions rather than those that create a greater divide?

    • Jarrod McMaugh

      you make it sound like no one’s putting in a lot of hard work and effort to do just that Alexander.

      Do you have any suggestions for new initiatives for which no stakeholder will have an objection? I’d be very happy to look at implementing anything you come up with that meets that criteria

      • Sure there are – I’ve mentioned it multiple times in the past. Definitely more moderate and tolerable.

        • Jarrod McMaugh

          I don’t recall any suggestions you have made that all stakeholders would support.

          Perhaps you can refresh my memory

          • United we stand

            Here’s what we should be fighting for:

            1. Medicare subsidised Consultation fee for checking Drug-Drug and Drug-herb interactions

            2. Medicare subsidised consultation fee for diagnosing minor ailments

            3. Expanding Drug Tariff list of extemporaneous preparations to make compounded medications more affordable for Australian population

            4. Allowing compounded medicines substituting medicines listed on TGA Drug Shortage list to be subsidised under PBS.

            5. Medicare subsidy for administration of vaccine by a trained pharmacist

            6. Medicare subsidy for phone consultations that can go for half an hour to ensure medications are used correctly.

            7. Medicare subsidy for ensuring antimicrobial stewardship protocols are upheld.

            Instead we want to play doctor just to put more dollars in our rich daddy’s pockets (aka shop owners)

          • Jarrod McMaugh

            Good list

            Although I was asking Alexander for initiatives he’s raised in the past where all stakeholders will be on board…..

Leave a reply